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Wound re-epithelialization represents a tissue move-
ment that crucially participates in wound closure.
Recently, we demonstrated that supplemented leptin
improved re-epithelialization processes in leptin-de®-
cient ob/ob mice. In this study we investigated regu-
lation of the leptin system during normal repair in
healthy animals. We found leptin to be present at the
wound site during healing, although leptin levels
were clearly reduced upon injury compared with
uninvolved control skin. The functional leptin recep-
tor subtype obRb was observed to be constitutively
expressed in nonwounded skin. During early healing,
the leptin receptor obRb was downregulated, but re-
increased again from day 5 postwounding.
Immunohistochemistry revealed that highly prolif-
erative keratinocytes of the wound margin epithelia
strongly expressed the functional leptin receptor sub-
type obRb. In vitro studies demonstrated that murine
and human primary epidermal keratinocytes
responded to exogenously added leptin with a prolif-
erative response. Moreover, speci®city of leptin-
mediated mitogenic effects on primary keratinocytes
could be shown by completely blocking leptin
actions by a soluble, nonfunctional chimeric leptin
receptor. Finally, we report that leptin, besides the
recently described activation of the janus tyrosine
kinase signal transducers, also activated extracellular
signal-regulated kinase-controlled signaling pathways
in primary keratinocytes. Key words: epidermis/injury/
proliferation. J Invest Dermatol 117:98±105, 2001
W
ound healing disorders are a therapeutic pro-
blem of extensive clinical importance. Thus, it is
reasonable to search for novel factors regulating
wound healing processes to establish novel
therapeutic approaches. Re-epithelialization is
central to wound closure and driven by movements of epithelial
keratinocytes. After a lag period of several hours after skin injury,
these movements are initiated starting with epidermal migration
(Stenn and Depalma, 1988; Martin, 1997). Subsequently, the
injury-mediated loss of epidermal keratinocytes is replaced by the
generation of keratinocytes from the newly formed highly
proliferative epithelia at the wound margins, which now feed the
moving epithelial tongue. Growth factors and cytokines participate
in the close regulation of keratinocyte behavior during these
processes. Thus, epidermal growth factor (EGF) and keratinocyte
growth factor (KGF) are well known to be potent mitogens for
epithelial cells, and therefore essentially involved in re-epithelia-
lization during skin repair (Nanney, 1990; Werner et al, 1994;
Marchese et al, 1995).
Recently, we revealed that the ob gene product leptin, which has
been characterized as a satiety-regulating cytokine and which is
predominantly expressed by adipocytes and secreted into the
bloodstream (Zhang et al, 1994; Masuzaki et al, 1995), markedly
improves the severely disturbed wound healing conditions that are
associated with the loss of a functional leptin system in obese/obese
(ob/ob) mice (Frank et al, 2000). Systemically and also topically
administered recombinant leptin improved re-epithelialization of
excisional wounds in the leptin-de®cient ob/ob mouse model of
impaired skin repair.
Leptin is structurally related to cytokines (Zhang et al, 1997)
and acts on receptors that have considerable homology to class I
cytokine receptors (Tartaglia et al, 1995). Among several leptin
receptor (obR) isoforms, the appetite-regulating effect of leptin
has been shown to be dependent on binding of leptin to the
corresponding leptin receptor subtype obRb in the hypotha-
lamic region (Ghilardi et al, 1996; Lee et al, 1996; Vaisse et al,
1996). Leptin function is restricted to binding of its only
currently known functional receptor variant obRb. The obRb
splice variant is the only leptin receptor that mediates an
intracellular signaling by transphosphorylation of janus tyrosine
kinases (jak) followed by a subsequent activation of signal
transducers and activators of transcription (STAT) proteins (Ihle,
1995; Bjorbaek et al, 1997). The absence of a functional leptin
in ob/ob mice (Zhang et al, 1994) or, additionally, the loss of
the intracellular domain of the leptin receptor subtype obRb in
db/db mice (Chen et al, 1996; Lee et al, 1996) results in
decreased lipolytic activity and an increase of food intake
(Halaas et al, 1995; Ghilardi et al, 1996; Vaisse et al, 1996).
Thus, these animals exhibit a severe obesity and a diabetic
phenotype (Coleman, 1982).
Although supplemented leptin has been recently described to
reconstitute epithelial regeneration defects in leptin-de®cient ob/
ob mice and wild-type mice (Frank et al, 2000), the regulation
and potential function of the leptin±obRb leptin receptor
system remains to be investigated, especially in nondisturbed
wound healing processes in healthy animals. To this end, we
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determined expression patterns of leptin and its receptor subtype
obRb during normal skin repair. Here we demonstrate the
presence of leptin at the wound site and a transient decline in
obRb expression levels upon injury. Moreover, especially
proliferating keratinocytes located at the wound margins
strongly expressed the functional leptin receptor obRb. These
in vivo ®ndings were further supported by the observation that
leptin mediated a mitogenic stimulus to primary keratinocytes
in vitro. Thus, our data suggest a novel role for leptin as a
keratinocyte mitogen during skin repair.
MATERIALS AND METHODS
Animals Female BALB/C mice were obtained from Charles River
(Sulzfeld, Germany) and maintained under a 12 h light/12 h dark cycle
at 22°C until they were 12 wk of age. At this time they were caged by
four, monitored for body weight, and wounded as described below.
Wounding and preparation of wound tissues To examine leptin
functions on the wound healing process, six full-thickness wounds were
created on the backs of female BALB/C mice. Animals were
anesthetized with a single intraperitoneal injection of Ketamin (80 mg
per kg body weight)/Xylazin (10 mg per kg body weight). The hair on
the back of the mice was cut, and the back was subsequently wiped with
70% ethanol. Six full-thickness wounds (5 mm in diameter, 3±4 mm
apart) were made on the backs of the mice by excising the skin and the
underlying panniculus carnosus. The wounds were allowed to form a scab.
Skin biopsy specimens from four animals were obtained 6 h, or 1, 3, 5,
7, and 13 d after injury. An area 7±8 mm in diameter that included the
scab and the complete epithelial margins was excised at each time point.
As controls, a similar amount of nonwounded skin was taken from the
backs of four nonwounded mice, and from the backs of wounded
animals, respectively. For every experimental time point, the wounds
from four animals and the nonwounded back skin from four animals
were combined and used for RNA (n = 16 wounds) and protein
isolation (n = 8 wounds), respectively. All animal experiments were
carried out according to the guidelines and with the permission of the
local government of Hessen.
RNA isolation and RNase protection analysis RNA isolation was
performed as described previously (Chomczynski and Sacchi, 1987).
Twenty micrograms of total RNA from wounded or nonwounded skin
were used for RNase protection assays. RNase protection assays were
carried out as described previously (Werner et al, 1992), with four
different sets of RNA from four independent wound healing
experiments. The murine cDNA probes for leptin and the leptin
receptor obRb were cloned by reverse-transcriptase polymerase chain
reaction (RT-PCR). The cloned cDNA fragments correspond to
nucleotides 62±389 (for leptin) or nucleotides 506±871 (for leptin
receptor obR) of the published sequences (Zhang et al, 1994; Tartaglia
et al, 1995). RNases A and T1 were from Roche Biochemicals
(Mannheim, Germany).
Western blot analysis Skin lysates were prepared as described
previously (Frank et al, 1999; Stallmeyer et al, 1999). Total protein
(50 mg) from nonwounded back skin and 1, 3, 5, 7, and 13 d wounds
were separated using sodium dodecyl sulfate gel electrophoresis. For the
cell culture experiments, cell lysates from murine or human primary
keratinocytes were prepared as described previously (KaÈmpfer et al,
1999). After transfer to a PVDF membrane, leptin receptor obRa- and
obRb-speci®c proteins were detected using a polyclonal antiserum
directed against a synthetic peptide whose sequence is derived from
amino acids 577±594 of the mouse leptin receptor (ABR, Golden, CO).
Phosphorylated extracellular-factor-regulated kinase 1 (pERK 1) -speci®c
or ERK-1-speci®c proteins were determined using polyclonal antibodies
raised against the rat ERK-1-encoded p44 (for pERK 1) or human ERK
1 (for ERK 1) (Santa Cruz, Heidelberg, Germany), respectively. A
secondary antibody coupled to horseradish peroxidase (Biomol,
Hamburg, Germany) and the enhanced chemiluminescence detection
system were used to visualize leptin receptor protein.
Histologic analysis Mice were wounded as described above. At days
5, 7, and 13 after wounding mice were sacri®ced, and complete wounds
were isolated from the middle of the back, bisected, and frozen in tissue-
freezing medium. Immunohistochemistry was carried out on directly
neighboring 6 mm frozen serial sections as described previously (Frank
et al, 1999; Stallmeyer et al, 1999). Sections were incubated for 60 min at
room temperature with a polyclonal antibody raised against the COOH-
terminus of the murine obRb leptin receptor subtype (Santa Cruz,
Heidelberg, Germany), or a polyclonal antiserum raised against murine
Ki67 (Dianova, Hamburg, Germany) diluted 1:100 in phosphate-buffered
saline, 0.1% bovine serum albumin.
Cell culture of murine primary keratinocytes Murine primary
epidermal keratinocytes were isolated and maintained as described by
Hager et al (1999) in a de®ned keratinocyte medium (KBM) containing
0.06 mM Ca2+ (BioWhittaker Europe, Verviers, Belgium).
Cell culture of human primary keratinocytes Human primary
epidermal keratinocytes were purchased from BioWhittaker Europe.
Figure 1. Regulation of leptin expression during wound healing.
(A) Upper panel: Total cellular RNA (20 mg) from normal and wounded
back skin isolated from BALB/C mice was analyzed by RNase
protection assay for expression of leptin. Sixteen wounds (n = 16) from
the backs of four animals were excised for each experimental time point
and used for RNA isolation. The time after injury and number of the
experimental series is indicated at the top of each lane. Control skin refers
to nonwounded skin. 1000 cpm of the hybridization probe were added
to the lane labeled probe. Expression of GAPDH mRNA is shown as a
loading control. The degree of leptin induction as assessed by
PhosphoImager (Fuji) analysis of the radiolabeled gels is shown
schematically in the lower panel. For the lower panel, note that every
experimental time point represents a total of 64 wounds (n = 64) from
four independent animal experiments. (B) Total protein (50 mg) from
lysates of nonwounded and wounded back skin (days 1, 3, 5, 7, and 13
after injury, as indicated) of BALB/C mice was analyzed by ELISA for
the presence of leptin-speci®c protein. Sixteen wounds (n = 16) from
the backs of eight animals were excised for each experimental time point
and used for protein isolation. Control refers to nonwounded back skin
of BALB/C mice. Data are expressed as x-fold induction 6 SD
compared to control or as pg per 50 mg total wound protein 6 SD.
*p < 0.05; **p < 0.01 compared to control.
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Cells were cultured in a de®ned keratinocyte medium (KBM-2)
according to the instructions of the supplier.
Proliferation assay (MTS) Murine primary keratinocytes were seeded
on 96-well plates. Each well contained 103 cells in a total volume of
100 ml of KBM. Subsequently, cells were grown for 24 h. The
proliferation rate of incubated cells was determined after a 24 h
stimulation with leptin (100 ng per ml) using the CellTiter 96 Aqueous
One Solution Cell Proliferation Assay (Promega, Mannheim, Germany)
according to the instructions of the manufacturer. This assay determines
the number of viable cells in proliferation assays, because the total
amount of the formed formazan end product is directly proportional to
the number of living cells in culture. For the experiment using the
nonfunctional leptin receptor, 5 3 102 cells were seeded and leptin-
stimulated (1 ng per ml) for 48 h in the presence or absence of the leptin
receptor/IgG1 Fc chimeric protein (100 ng per ml) (R&D Systems,
Wiesbaden, Germany) before proliferation rates were determined.
Murine recombinant leptin was purchased from R&D Systems, and KGF
and EGF were from Roche Biochemicals.
Proliferation assay (BrdU) Human primary keratinocytes were
seeded on 96-well plates. Each well contained 5 3 102 cells in a total
volume of 100 ml of KBM-2. Subsequently, cells were grown for 24 h.
The proliferation rate of incubated cells was determined after a 24 h
stimulation with leptin (100 ng per ml), KGF (10 ng per ml), or EGF
(10 ng per ml). After growth factor incubation, 5-bromo-2¢-
deoxyuridine (BrdU) labeling reagent (Roche Biochemicals) was added
for an additional 1 h incubation. BrdU incorporation during cellular S-
phase, as assessed by BrdU colorimetric cell proliferation enzyme-linked
immunosorbent assay (ELISA) (Roche Biochemicals), was used as a
direct readout for cell proliferation rates. Human recombinant leptin was
from R&D Systems.
ELISA Total protein (50 mg diluted in lysis buffer to a ®nal volume of
50 ml) from nonwounded skin lysates and wound lysates, respectively,
was subsequently analyzed for the presence of immunoreactive leptin
protein by ELISA using the Quantikine murine leptin kit (R&D
Systems) as described by the manufacturer.
Statistical analysis Data are shown as means 6 SD. Data were
analyzed by unpaired Student's t test on raw data using Sigma Plot
(Jandel Scienti®c, Erkrath, Germany).
RESULTS
Regulation of cutaneous leptin mRNA expression after
injury and availability of leptin protein during repair As we
have shown leptin to enhance wound closure in leptin-de®cient
ob/ob mice (Frank et al, 2000), we were interested in whether the
leptin±obRb leptin receptor system might also participate in normal
repair. Therefore we ®rst investigated the time course of leptin
mRNA and protein expression during this process in healthy
BALB/C mice. We isolated total RNA from full-thickness
excisional wounds at different intervals after injury and performed
RNase protection assays. RNA from four independent wound
healing experiments was analyzed for leptin expression. For the
RNase protection assay shown in Fig 1(A) (upper panel), it should
be noted that every experimental time point represents 16 control
skin or wound biopsy specimens (n = 16) isolated from four
animals. As shown in Fig 1, we could detect a low level of basal
expression of leptin mRNA in normal back skin (ctrl skin). Upon
injury, a rapid increase (about 3±4-fold) in leptin mRNA
expression was observed. The observed increase was only
transient, as leptin mRNA levels were only slightly elevated from
day 3 postwounding. It should be noted that every experimental
time point in Fig 1(A) (lower panel) represents a total of 64 control
skin or wound biopsy specimens (n = 64) from four independent
wound healing experiments.
As a next step, we determined whether the increase in leptin
mRNA levels upon injury was subsequently followed by increasing
leptin protein levels within the wound. This was important, as
leptin is mainly produced by adipocytes and secreted into the
bloodstream (Zhang et al, 1994; Masuzaki et al, 1995). This
observation raised the question whether locally expressed leptin
mRNA at the wound site (Fig 1A) translates into leptin protein
that is available at the site of repair rather than ``being lost'' from the
wound site by secretion into the blood stream. Furthermore, leptin
that was not produced in the skin but in other organ systems of the
body might also be transported into the wound via the vasculature.
To clarify this question, we measured leptin concentrations in
normal skin and wound lysates using a sensitive ELISA technique.
We observed a constitutive expression of leptin in nonwounded
back skin, which markedly declined upon injury by about 50%
(Fig 1B). The decline in leptin protein was only transient, as we
determined re-increasing leptin levels from day 3 postwounding
that nearly reached levels of nonwounded skin after 13 d of repair.
Expression of the leptin receptor during repair As we had
observed leptin to be present at the wound site, we subsequently
investigated the expression pattern of the leptin receptor in normal
skin and during cutaneous repair. Until now, six different splice
variants of the leptin receptor gene have been identi®ed, of which
only the obRb isoform has been demonstrated to mediate
intracellular signaling (Ghilardi et al, 1996). To investigate
regulation of obR mRNA and protein expression during repair,
we performed RNase protection assay (Fig 2A), Western blot
analysis (Fig 2B), and immunohistochemistry (Fig 4). We used an
antisense RNA probe that hybridized to an mRNA region
recognizing both obRa and obRb. As shown in Fig 2, obR
mRNA and protein were expressed in nonwounded skin, but
wounding led to a rapid decline in obR mRNA and protein levels.
Minimal obR expression was observed 3 d after wounding. obR
mRNA levels started to re-increase again 5 d after injury (Fig 2A).
Weak signals for obRb-speci®c proteins could be detected after 7 d
postwounding, but clearly visible signals appeared after 13 d of
repair (Fig 2B).
Figure 2. Expression of the leptin receptor obR upon injury. (A)
Total cellular RNA (20 mg) from nonwounded and wounded back skin
of BALB/C mice was analyzed by RNase protection assay with an RNA
hybridization probe complementary to the obRa and obRb leptin
receptor splice variants. For every experimental time point, four wounds
each from four animals (n = 16 wounds) were pooled for analysis. The
time after injury is indicated for each lane. Ctrl skin refers to
nonwounded skin. Hybridization probe (1000 cpm) was added to the
lane labeled probe. Expression of GAPDH mRNA is shown as a loading
control. One representative out of four experiments is shown. (B) Total
protein (50 mg) from lysates of nonwounded and wounded back skin
(days 1, 3, 5, 7, and 13 after injury, as indicated) of BALB/C mice was
analyzed by immunoblotting for the presence of leptin receptor subtype
proteins obRa and obRb. Sixteen wounds from eight animals (n = 16
wounds) were excised for each experimental time point and used for
protein isolation. Leptin receptor subtypes obRa and obRb are indicated
by arrows. One representative out of four experiments is shown.
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Trauma of wounding did not alter basal expression levels of
leptin and its receptor (obR) in nonwounded skin areas of
injured mice For the wound healing experiments, skin from
nonwounded mice served as the control that represented the
normal, noninjured situation. Nevertheless, it is tempting to argue
that the trauma of wounding, including anesthesia, pain, or
systemic effects resulting from surgery, might alter basal leptin and
leptin receptor (obR) expression. Thus, possible alterations in
leptin and obR expression upon wounding surgery might
contribute to the observed expressional changes in leptin and its
receptor at the wound site. To exclude systemic effects of the
wounding procedure on leptin and obR expression, mice were
wounded as described (see Materials and Methods). Six hours or 24 h
after the initial wounding, respectively, nonwounded skin located
adjacent to the wound sites was taken as an additional control. As
shown in Fig 3, wounding did not signi®cantly alter cutaneous
expression of leptin (Fig 3A) or leptin receptor (Fig 3B) mRNA
in nonwounded skin areas that now served as additional controls.
Accordingly, expression of leptin and its receptor obR was not
in¯uenced by systemic effects induced by the wounding procedure.
The ctrl skin lane represents a total of 16 biopsy specimens of
nonwounded skin (n = 16) from four different animals (n = 4) that
had been pooled prior to analysis. It is important to note that the
other data points depicted represent three biopsy specimens each of
nonwounded skin (n = 3) that had been isolated for analysis from
``control-wounded'' individual animals (mouse #1 to #6) 6 h and
24 h after injury.
Expression of the leptin receptor subtype obRb was
associated with keratinocyte proliferation during
repair The absence of obRb-speci®c signals at days 5±7 after
injury, compared to re-increasing obR mRNA expression at these
time points, could be due to a limited sensitivity of the Western
blot analysis, especially as many cytokine receptors are known to be
expressed in limited amounts. To solve this problem, we performed
a sensitive immunohistochemistry analysis using 6 mm frozen serial
sections from 5, 7, and 13 d wounds. Furthermore, as leptin was
available at the wound site, it was important to determine the
potential target cells for leptin at the wound site. As shown in
Fig 4, we indeed detected the obRb receptor variant to be strongly
expressed in 5, 7, and 13 d wounds, thus con®rming the data
obtained at the mRNA level. In control skin, obRb protein was
speci®cally expressed in keratinocytes of the basal layer of the
epidermis (data not shown). The same expression pattern for obRb
was observed in completely re-epithelialized wounds 13 d after
injury (Fig 4, lower panel). Moreover, obRb expression was not
restricted to the basal layer of the epidermis during repair, as strong
immunopositive signals could be detected in keratinocytes of the
hyperproliferative epithelia at the wound margins (Fig 4, upper
panel). As expression of the obRb leptin receptor isoform was
clearly con®ned to proliferating keratinocytes of the epidermal basal
layer and the hyperproliferative epithelium, we hypothesized that
leptin might mediate a mitogenic stimulus to keratinocytes located
at the wound margins. To this end, we stained directly neighboring
6 mm serial frozen sections from 5, 7, and 13 d wounds for obRb
protein expression and expression of the proliferation marker Ki67
(Gerdes et al, 1984), respectively (Fig 4). Not unexpectedly, we
observed a clear correlation between obRb-immunopositive
(Fig 4, left panels) and proliferating (Fig 4, right panels)
keratinocytes. It is noteworthy that the obRb was expressed
throughout nearly all keratinocytes of the hyperproliferative
epithelia (Fig 4, upper left panel). This phenomenon clearly
correlated with the highly mitogenic activity of wound margin
keratinocytes at this stage of tissue regeneration (Fig 4, upper right
panel), whereas keratinocyte obRb expression and, additionally,
keratinocyte mitogenic activity became more and more restricted
to the basal layers of the forming neo-epithelium at later stages of
repair (Fig 4, middle and lower panels).
Leptin-enhanced proliferation in primary keratinocytes To
further strengthen our in vivo observations, we determined the
mitogenic potency of leptin in murine and human primary
keratinocytes in vitro. First, we investigated whether isolated
murine and human primary keratinocytes expressed the obRb
receptor subtype and thus could respond as target cells for leptin
functions. Indeed, we could assess the presence of the obRb
receptor variant by reverse transcriptase ampli®cation and
subsequent cloning and sequencing of the ampli®ed obRb cDNA
fragment for both murine and human primary keratinocytes (data
not shown). Additionally, we con®rmed these data by Western blot
analysis for cultured murine cells. As shown in Fig 5(A), we could
clearly detect expression of both obRa and, more importantly, the
functional obRb receptor isoform in murine primary keratinocytes
from passages 1 (P1) and 3 (P3). As the anti-obR antibody used
(ABR) recognizes all obR splice variants, the additional bands
might represent additionally expressed obR subtypes. Obviously,
exogenously added leptin mediated a mitogenic stimulus towards
the cells in a dose-dependent manner (Fig 5B). It is noteworthy
that even the lowest concentrations of leptin (0.1 ng per ml)
triggered a proliferative response in keratinocytes. To further
strengthen our observation, we assessed the speci®city of leptin
action on keratinocytes using a chimeric leptin receptor (R&D
Systems). This chimeric receptor consists of the leptin receptor
extracellular domain fused to human IgG1 Fc. Primary
keratinocytes were stimulated by leptin (1 ng per ml) in the
presence or absence of this soluble chimeric leptin decoy receptor
(100 ng per ml). Indeed, the observed mitogenic effects in
keratinocytes could be proven to be leptin-speci®c, as the
nonfunctional soluble leptin receptor completely blocked leptin-
mediated proliferation of the cells (Fig 5C).
The MTS assay represents a direct readout for mitochondrial
activity, however. Thus, the observed increase in formazan end
Figure 3. Wounding trauma did not in¯uence leptin and leptin
receptor expression in nonwounded skin areas. Upper panels: Total
cellular RNA (20 mg) from nonwounded back skin isolated from
nonwounded mice (ctrl skin) or isolated from ``control-wounded''
animals (mouse #1 to #6) 6 h and 24 h after wounding was analyzed by
RNase protection assay using RNA antisense probes speci®c for leptin
and the obRa and obRb leptin receptor splice variant (obR) as indicated.
For ctrl skin, 16 biopsy specimens of nonwounded skin (n = 16) from the
backs of four nonwounded animals were pooled and subsequently
analyzed. For mouse #1 to #6, three biopsy specimens each of
nonwounded skin (n = 3) adjacent to the sites of injury were isolated,
pooled, and analyzed. The time after injury is given in brackets. 1000
cpm of the hybridization probe were added to the lane labeled probe.
Expression of GAPDH is shown as a loading control. The degree of
basal leptin and obR expression as assessed by PhosphoImager (Fuji)
analysis of the radiolabeled gels is shown schematically in the lower panels
as indicated. Mean expression values 6 SD are shown. Ctrl represents 16
biopsy specimens (n = 16) of four different animals, 6 h and 24 h
postwounding represent nine biopsy specimens each (n = 9) from three
different animals (mouse #1 to #3 and mouse #4 to #6). n.s., not
signi®cant compared to control (ctrl).
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product is directly proportional to the number of viable cells in
culture, and thus might re¯ect leptin-mediated cell survival rather
than leptin-mediated mitogenic effects. To solve this problem, we
determined the mitogenic potency of leptin in human primary
keratinocytes using BrdU. BrdU is incorporated into the DNA of
cells speci®cally during S-phase and serves as a readout for cell
proliferation independent from cell survival. Please note that we
have added BrdU into the culture medium for only 60 min after a
24 h leptin pretreatment of the cells. To this end, we were able to
speci®cally detect actively proliferating keratinocytes (and not only
viable cells, which contribute to an increased formazan signal in the
MTS assay) within this de®ned experimental time window. As
shown in Fig 6(A), we could con®rm the mitogenic potency of
leptin also for human primary keratinocytes. Moreover, the pro-
Figure 5. Effect of leptin on proliferation in murine primary keratinocytes. (A) Expression of obRa and obRb leptin receptor isoforms in
murine primary keratinocytes. Cells were grown in a de®ned keratinocyte medium (KBM) and harvested after passage 1 or 3 after isolation as
indicated. Total protein (50 mg) from the cells was analyzed by immunoblotting for the presence of obR-speci®c proteins. ObRa and obRb proteins
are indicated by an arrow. (B) Dose-dependent effects of murine recombinant leptin (0.1±500 ng per ml) on proliferation of primary murine epidermal
keratinocytes. (C) Leptin-mediated keratinocyte proliferation was completely blocked by the soluble leptin receptor IgG1 Fc chimera. Cells were
treated with murine recombinant leptin (1 ng per ml) in the presence or absence of the leptin receptor IgG1 Fc chimera (100 ng per ml). For (B) and
(C), proliferation was determined using the MTS reagent as described in Materials and Methods. Data are expressed as percentage of unstimulated
control. Mean percentage change in proliferation 6 SD is shown (values represent the mean of six assays with a readout of nine wells for each
condition; n = 54). *p < 0.05; **p < 0.01; n.s., not signi®cant compared with control.
Figure 4. Localization of leptin receptor
subtype obRb in regenerating skin. Directly
neighboring frozen serial sections from mouse
wounds (day 5, 7, and 13, as indicated) were
incubated with a polyclonal antibody directed
against the murine leptin receptor subtype obRb
(left panels) and the polyclonal antibody against the
proliferation marker protein Ki67 (right panels),
respectively. All sections were stained with the
avidin±biotin-peroxidase complex system using 3-
amino-9-ethylcarbazole as a chromogenic
substrate. Nuclei were counterstained with
hematoxylin. Strongly immunopositive signals
within the sections are indicated with arrows. g,
granulation tissue; he, hyperproliferative
epithelium, ne, neo-epithelium.
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proliferative effect of leptin was comparable to the well-established
and potent keratinocyte mitogens KGF and EGF (Fig 6B).
Leptin-mediated activation of ERK in primary human
keratinocytes Stimulation of obRb leads to activation of
different intracellular signaling pathways. On one hand,
stimulation of obRb activates jak that then trigger STAT
activation and translocation into the nucleus (Ihle, 1995;
Bjorbaek et al, 1997). On the other hand, an activation of ERK
has also been described after leptin stimulation of obRb (Bjorbaek
et al, 1997). As we have reported leptin-mediated activation of the
jak±STAT pathway in human primary keratinocytes (Frank et al,
2000), we ®nally assessed the possibility that activation of the ERK
pathway might also participate in the observed leptin-mediated
mitogenic responses in primary keratinocytes. Using an antibody
raised against pERK 1 (Santa Cruz), we could observe an increase
in pERK 1, indicating that leptin stimulation of obRb indeed led to
an activation of the ERK pathway in keratinocytes (Fig 7). It is
noteworthy that the relatively high basal levels of pERK 1 observed
in nontreated cells (ctrl) were due to a mitogenic prestimulation of
the cells, as the de®ned keratinocyte medium (KBM-2) contained
0.1 ng per ml of the potent keratinocyte mitogen EGF.
DISCUSSION
Ob/ob mice have been widely used for many years as a model
system for impaired wound healing. It is well known that a
mutation in the ob gene, which encodes the ob gene product leptin,
causes the altered phenotype of these animals (Zhang et al, 1994).
As the genetic background C57/BL6J gives rise to a moderate
diabetic phenotype that occurs only transiently and predominantly
in early developmental stages (Coleman, 1982), however, the
moderate hyperglycemia probably does not represent the only
reason for the impaired wound healing observed in leptin-de®cient
ob/ob mice.
Recent work from Ring and colleagues reported an acceleration
in wound repair in ob/ob mice after systemic and topical application
of recombinant leptin after wounding (Ring et al, 2000). The
failure of leptin to improve repair in db/db mice clearly indicated
that the effects of leptin were mediated through the leptin receptor
subtype obRb, which is nonfunctional in these animals (Ghilardi
et al, 1996). Additionally, the study demonstrated expression of all
splice variants of the leptin receptor obR to be restricted to
cutaneous blood vessels in murine skin (Ring et al, 2000).
Moreover, the authors did not observe signi®cant changes in
wound vessel density after application of leptin in ob/ob mice (Ring
et al, 2000), which contrasts with the suggested role of leptin in
promoting angiogenesis (BouloumieÂ et al, 1998; Sierra-Honigmann
et al, 1998).
Work from our laboratory recently provided an explanation for
the observed potency of leptin for improving impaired wound
healing conditions in leptin-de®cient mice, however: systemically
and topically supplemented leptin improved re-epithelialization of
wounds in these animals (Frank et al, 2000). Leptin completely
reversed the atrophied morphology of the migrating epithelial
tongue observed at the wound margins of leptin-de®cient animals
into a well-organized hyperproliferative epithelium. Keratinocytes
located at the wound margins were observed to strongly express the
obRb splice variant in ob/ob mice (Frank et al, 2000). The reason
for the disparate observations reported by Ring et al (2000) is not
yet clear. Nevertheless, as these animals represent a natural
knockout model for the cytokine leptin, expression of the leptin±
leptin receptor system might be differentially regulated in healthy
animals.
In order to address this question, we determined leptin and its
functional receptor obRb during a normal and undisturbed wound
healing process. As observed for ob/ob mice (Frank et al, 2000), we
found expression of the functional leptin receptor variant obRb
speci®cally targeted to the epithelial compartment. More import-
antly, staining of directly neighboring serial sections against obRb
and the proliferation marker Ki67 (Gerdes et al, 1984) revealed a
close correlation between keratinocyte-speci®c expression of obRb
and the mitogenic behavior of wound keratinocytes. Interestingly,
proliferation of wound margin keratinocytes normally peaks around
day 5 postwounding (S. Frank, unpublished observations), and this
is the time point when nearly all keratinocytes of the forming
hyperproliferative epithelia strongly expressed the obRb protein.
Notably, immunohistochemistry (instead of the much less sensitive
Western blot analysis) clearly revealed a strong expression of obRb
protein in wound margin keratinocytes that temporally paralleled
the time window of highest keratinocyte proliferation during
repair. It is important to note that many obRb-expressing
keratinocytes were negative for Ki67 expression from day 7
postwounding on. This observation indicates that, as keratinocyte
proliferation rates declined, obRb expression got more and more
restricted to the basal layers of the forming neo-epithelium and that
cell proliferation is only partially controlled via a functional leptin±
obRb system. The in vivo correlation between obRb expression
and keratinocyte proliferation is strongly supported by previous
data from our laboratory. We could demonstrate a more than 40%
increase in Ki67-immunopositive wound margin keratinocytes in
leptin-de®cient ob/ob mice that had been supplemented with
recombinant leptin during repair (Frank et al, 2000).
Figure 6. Leptin mediates a mitogenic stimulus to human
primary keratinocytes. (A) Dose-dependent effects of human
recombinant leptin (0.1±500 ng per ml) on human primary keratinocyte
proliferation. Proliferation was determined by BrdU incorporation. Data
are expressed as percentage of unstimulated control. Mean percentage
change in proliferation (BrdU incorporation) 6 SD is shown (n = 45
wells for each condition). **p < 0.01 compared with control. (B) Effects
of leptin (100 ng per ml), KGF (10 ng per ml), or EGF (10 ng per ml)
on human primary keratinocytes. Proliferation was determined by MTS
reagent and BrdU incorporation as indicated. Data are expressed as
percent of unstimulated control. Mean percentage change in proliferation
6 SD is shown (n = 54 wells for each condition). **p < 0.01 compared
with control.
Figure 7. Leptin-mediated activation of the ERK pathway in
human primary keratinocytes. Human primary epidermal
keratinocytes were grown to con¯uence in a de®ned keratinocyte
medium (KBM-2). Cells were treated with human recombinant leptin
(100 ng per ml) and subsequently harvested at the indicated time points.
Total cellular protein (50 mg) from the cells was analyzed for the
presence of pERK 1 (upper panel). Note that activation of ctrl cells was
due to the presence of EGF (0.1 ng per ml) in the de®ned KBM-2
medium. One representative experiment is shown. The same blot was
analyzed for non-pERK 1 as a loading control (lower panel).
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The formation of new epithelial structures has to be tightly
controlled. Key players driving these processes are protein-type
cytokines, growth factors, mitogens (Clark, 1996; Martin, 1997),
and the small radical gas nitric oxide (Stallmeyer et al, 1999).
Among these factors, one is well known to be unique for epithelial
repair processes: KGF (Werner, 1998). KGF is largely induced in
dermal ®broblasts early during wound repair and shows highly
elevated levels during the process of re-epithelialization.
Accordingly, the KGF receptor is found to be expressed in
proliferating wound keratinocytes, thus suggesting a paracrine
mode of action (Werner et al, 1992). For this reason, it was exciting
to observe expression of the functional leptin receptor obRb in
proliferative wound keratinocytes and basal keratinocytes of the
neo-epithelium. Although both the KGF (Werner et al, 1994) and
the leptin system (Frank et al, 2000; this study) participate in
keratinocyte proliferation in vivo, both systems appear to be
differentially regulated during repair. Moreover, as KGF represents
a mitogen for epithelial cells (Rubin et al, 1989), leptin has been
reported to serve as a mitogen for a growing number of different
cell types (Tanabe et al, 1997; BouloumieÂ et al, 1998; Santos-
Alvarez et al, 1999; Tsuchiya et al, 1999). In contrast to the injury-
inducible KGF system, which crucially participates in re-epithelia-
lization processes (Werner et al, 1994), we observed a constitutive
expression of leptin in normal skin. Upon injury, leptin concen-
trations at the wound site declined, in contrast to KGF, which is
strongly induced. Interestingly, subcutaneous adipocytes were
reported to represent main producers of leptin (Montague et al,
1997), and one explanation for decreasing leptin levels at the
wound site might be the loss of adipocyte-derived leptin into the
blood stream. Additionally, transforming growth factor b1 (TGF-
b1), which is released in large amounts from platelets upon injury,
has been demonstrated to enhance leptin mRNA expression in
cultured adipocytes, whereas leptin expression was inhibited by
pro-in¯ammatory cytokines such as interleukin-1b or tumor
necrosis factor-a in the cells (Granowitz, 1997). This report
supports and strengthens our in vivo observation of a transient
increase in leptin mRNA after injury, as platelet-released TGF-b1
temporally precedes immune-cell-derived cytokines at the wound
site after injury.
In contrast to the constitutive expression of the KGF receptor
(Werner et al, 1992) or elevated expression of the EGF receptor
(Stoscheck et al, 1992) in wound repair, the obRb leptin receptor
expression was downregulated early after injury. This phenomenon
tightly parallels the observed decreasing leptin concentrations at the
wound site. Accordingly, it is tempting to speculate that we have
measured receptor-bound leptin at the wound site, and thus that
functionally active leptin might be held in the wound bed by its
own receptor. By contrast to KGF or EGF actions, the down-
regulation of obRb after injury is most likely to target speci®cally
the mitogenic properties of leptin to later epithelial movements
during repair. As we identi®ed the obRb receptor subtype to be
speci®cally expressed in proliferating keratinocytes of the hyper-
proliferative epithelia and the basal layers of the neo-epithelium
during normal repair, it is tempting to speculate that the obRb
receptor variant might serve to target a mitogenic effect of leptin
towards the epithelial compartment. This hypothesis is strongly
supported by the fact that impaired epithelialization processes in
wounded ob/ob mice could be reversed by recombinant leptin
(Frank et al, 2000). The presence of a functionally active leptin
system during skin repair is further strengthened by the observation
that leptin accelerated re-epithelialization even in healthy BALB/C
mice (Frank et al, 2000). Moreover, leptin is most likely to act
speci®cally on the epidermal compartment. Interestingly, although
cutaneous blood vessels have been reported to express the obRb
splice variant (Ring et al, 2000), leptin failed to reconstitute the
severely impaired angiogenic response during wound repair in
leptin-de®cient ob/ob mice (Stallmeyer et al, 2001).
Finally, it was important to further strengthen a possible
correlation of obRb expression and keratinocyte proliferation, as
the immunohistochemistry data strongly suggested a functional
correlation for the in vivo situation. Not unexpectedly, we observed
a strong mitogenic effect of leptin on primary epidermal
keratinocytes, which was dose dependent and, more importantly,
could be completely blocked by a soluble leptin receptor/IgG1 Fc
chimera. These data con®rmed our recent report, where human
primary keratinocytes responded to a leptin stimulus with an
increased mitogenic activity (Frank et al, 2000). Interestingly, ERK
pathways could be activated by leptin in human primary
keratinocytes (this study), thus demonstrating that leptin indeed
stimulated intracellular pathways that participate in mitogenic
responses.
In summary, we have observed a close regulation of leptin and its
receptor obRb during repair. Leptin action is targeted towards the
epithelial compartment, as proliferating keratinocytes express the
functional obRb receptor subtype. Interestingly, leptin function
appeared to be temporally controlled by the restricted availability of
the obRb receptor variant at later stages (from day 5 on) of repair.
Finally, in vitro studies clearly supported a mitogenic effect of leptin
on primary epidermal keratinocytes. Thus, this study suggests a
novel function for leptin: to serve as a keratinocyte mitogen during
skin repair.
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